Meeting Reports for “2011 International Symposium on Respiratory Endoscope 
and Lung Cancer ” by Runbo ZHONG

Get full text

Prognostic value of pretreatment procalcitonin and neutrophil–lymphocyte ratio in extensive-stage small-cell lung cancer by Dongfang Chen, Jianlin Xu, Yizhuo Zhao, Baohui Han, Runbo Zhong

Get full text

Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer by Lian Yu, Jianlin Xu, Rong Qiao, Baohui Han, Hua Zhong, Runbo Zhong

Get full text

Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression by Yingqi Xu, Jianlin Xu, Rong Qiao, Hua Zhong, Jinjing Xia, Runbo Zhong

Get full text

Endobronchial Ultrasound-guided Transbronchial Needle Aspiration 
in the Diagnosis of Intrathoracic Metastasis from Extrapulmonary Malignancy by Jiayuan SUN, Liang BAO, Jiajun TENG, Runbo ZHONG, Weiqiong WENG, Qin ZHANG, Baohui HAN

Get full text

The Clinical Analysis of 21 Patients with Lymphoepithelioma-like Carcinoma after Operation by Jinjing XIA, Liyan JIANG, Jie ZHANG, Qian MIAO, Yu XIN, Runbo ZHONG, Yizhuo ZHAO, Baohui HAN

Get full text

Clinical Features and Outcomes Analysis of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant Chemotherapy by Yinchen Shen, Fang Hu, Changhui Li, Jianlin Xu, Runbo Zhong, Xueyan Zhang, Tianqing Chu, Baohui Han

Get full text

Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases by Rong Qiao, Runbo Zhong, Jianlin Xu, Yanwei Zhang, Bo Zhang, Shuyuan Wang, Yuqing Lou, Dongfang Chen, Qing Chang, Yizhuo Zhao, Baohui Han

Get full text

On-treatment lung immune prognostic index is predictive for first-line PD-1 inhibitor combined with chemotherapy in patients with non-small cell lung cancer by Anning Xiong, Jianlin Xu, Shuyuan Wang, Runbo Zhong, Jun Lu, Tianqing Chu, Wei Zhang, Ying Li, Xiaoxuan Zheng, Baohui Han, Wei Nie, Hua Zhong, Xueyan Zhang

Get full text

Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer by Anning Xiong, Wei Nie, Lei Cheng, Hua Zhong, Tianqing Chu, Runbo Zhong, Jun Lu, Shuyuan Wang, Jianlin Xu, Yinchen Shen, Feng Pan, Baohui Han, Xueyan Zhang

Get full text

Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive‐stage sma... by Bo Zhang, Hua Zhong, Chunlei Shi, Zhiqiang Gao, Runbo Zhong, Aiqin Gu, Weimin Wang, Tianqing Chu, Liwen Xiong, Wei Zhang, Huimin Wang, Xueyan Zhang, Baohui Han

Get full text

Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and... by Bo Zhang, Chunlei Shi, Zhiqiang Gao, Hua Zhong, Liwen Xiong, Aiqin Gu, Weimin Wang, Tianqing Chu, Wei Zhang, Huimin Wang, Xueyan Zhang, Runbo Zhong, Baohui Han

Get full text

TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer by Jun Lu, Jun Lu, Jun Lu, Runbo Zhong, Yuqing Lou, Minjuan Hu, Zhengyu Yang, Yanan Wang, Ya Chen, Benkun Zou, Wei Zhang, Huimin Wang, Baohui Han, Baohui Han, Baohui Han

Get full text

Osimertinib alone as second-line treatment for brain metastases (BM) control may be more limited than for non-BM in advanced NSCLC patients with an acquired EGFR T790M mutation by Changhui Li, Wei Nie, Jingdong Guo, Anning Xiong, Hua Zhong, Tianqing Chu, Runbo Zhong, Jianlin Xu, Jun Lu, Xiaoxuan Zheng, Bo Zhang, Yinchen Shen, Feng Pan, Baohui Han, Xueyan Zhang

Get full text

Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer by Liang Zheng, Anning Xiong, Shuyuan Wang, Jianlin Xu, Yinchen Shen, Runbo Zhong, Jun Lu, Tianqing Chu, Wei Zhang, Ying Li, Xiaoxuan Zheng, Baohui Han, Hua Zhong, Wei Nie, Xueyan Zhang

Get full text

hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527 by Changhui Li, Jiaqi Zhang, Xiaohua Yang, Cheng Hu, Tianqing Chu, Runbo Zhong, Yinchen Shen, Fang Hu, Feng Pan, Jianlin Xu, Jun Lu, Xiaoxuan Zheng, Hai Zhang, Wei Nie, Baohui Han, Xueyan Zhang

Get full text

Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer by Jun Lu, Ying Li, Wei Zhang, Hua Zhong, Fang Hu, Liang Zheng, Xiaohua Yang, Lin Huang, Xueyan Zhang, Tianqing Chu, Baohui Han, Yinchen Shen, Wei Nie, Jianlin Xu, Shuyuan Wang, Runbo Zhong, Xiaoxuan Zheng

Get full text

Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non‐small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line th... by Tianqing Chu, Jie Yuan, Jun Lu, Wei Nie, Runbo Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, Jialin Qian, Yanwei Zhang, Xueyan Zhang, Jiajun Teng, Zhiqiang Gao, Yuqing Lou, Jiaqi Li, Huiping Qiang, Chao Zhang, Jin Li, Xuefeng Xia, Hua Zhong, Baohui Han

Get full text